Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 6;13(1):19161.
doi: 10.1038/s41598-023-46270-1.

Kif21a deficiency leads to impaired glomerular filtration barrier function

Affiliations

Kif21a deficiency leads to impaired glomerular filtration barrier function

Hanna Riedmann et al. Sci Rep. .

Abstract

The renal glomerulus represents the major filtration body of the vertebrate nephron and is responsible for urine production and a number of other functions such as metabolic waste elimination and the regulation of water, electrolyte and acid-base balance. Podocytes are highly specialized epithelial cells that form a crucial part of the glomerular filtration barrier (GFB) by establishing a slit diaphragm for semipermeable plasma ultrafiltration. Defects of the GFB lead to proteinuria and impaired kidney function often resulting in end-stage renal failure. Although significant knowledge has been acquired in recent years, many aspects in podocyte biology are still incompletely understood. By using zebrafish as a vertebrate in vivo model, we report a novel role of the Kinesin-like motor protein Kif21a in glomerular filtration. Our studies demonstrate specific Kif21a localization to the podocytes. Its deficiency resulted in altered podocyte morphology leading to podocyte foot process effacement and altered slit diaphragm formation. Finally, we proved considerable functional consequences of Kif21a deficiency by demonstrating a leaky GFB resulting in severe proteinuria. Conclusively, our data identified a novel role of Kif21a for proper GFB function and adds another piece to the understanding of podocyte architecture and regulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Kif21a shows a specific expression during zebrafish development and localized to the glomerular filtration barrier. (A, B) Expression analysis of kif21a in zebrafish using semiquantitative reverse-transcription polymerase chain reaction (RT-PCR) on cDNA of different developmental embryonic stages (A) and adult organs (B). H2O served as negative control and ef1α as loading control; Primer dimer (PD). The grouping of gel images cropped from different parts of the same gel image is delineated with white spaces. (C) Whole-mount in situ hybridization (WISH) analysis detecting temporal and spatial kif21a expression at different stages during zebrafish embryonic development (white arrow marks the optic stalk at 18 somite stage; black arrowheads mark the somites at 1 day post-fertilization (dpf); white circle depicts the glomerular area). (D) Glomerular sections of 5dpf old Tg(wt1b:GFP) zebrafish embryos (green) that were immunostained for Kif21a (magenta) and counterstained with DAPI (blue) as a nuclear marker. A respective immunostaining without the secondary antibody served as negative control. Scale bar represents 25 µm. (E) Representative electron micrograph showing immunogold-labelling of Kif21a (magenta arrows) in the glomerular region from 5dpf old zebrafish embryos. Green arrowheads point to podocyte foot processes and black arrows mark the glomerular basement membrane. Bowman’s space (BS), capillary lumen (CL), fenestrated endothelial cell (EC). Scale bar represents 250 nm. Unprocessed gel images for (A and B) are presented in Supplementary Fig. S2.
Figure 2
Figure 2
Kif21a deficiency results in pericardial edema formation and reduced glomerular Kif21a signal in zebrafish. (A) Immunoblotting studies on zebrafish lysates of 4dpf old embryos injected with Control (Co)-MO (2 ng) or translation-blocking Morpholino (TB-MO) kif21a (1 or 2 ng) using a specific Kif21a antibody. γTubulin served as loading control. The grouping of blot images cropped from different parts of the same blot image is delineated with a white space. (B) Expression analysis of kif21a using semiquantitative RT-PCR on cDNA of Co-MO (4 ng) or splice-blocking Morpholino (SB-MO) kif21a (1, 2 or 4 ng). Black arrows point to kif21a wildtype (wt) PCR product and morphant (mo) PCR splice product; Primer dimer (PD). H2O served as negative control and ef1α as loading control; dividing lines indicate different contrast from different parts of the same gel image. (C) Glomerular sections of 5dpf old Tg(wt1b:GFP) zebrafish embryos (green) that were injected with Co-MO (6 ng), TB-MO kif21a (2 ng) or SB-MO kif21a (6 ng), immunostained for Kif21a (magenta) and counterstained with DAPI (blue) as a nuclear marker. A respective immunostaining without the secondary antibody of a Co-MO injected embryo served as negative control. Scale bar represents 25 µm. (D) Quantification reveals significant reduced Kif21a levels in the glomerulus of embryos injected with TB-MO kif21a (2 ng) or SB-MO kif21a (6 ng) compared to Co-MO (6 ng) injected embryos; Arbitrary Unit (A.U.). The barchart represents the pooled data from 3 different embryos for each condition. (E) Quantification of pericardial edema formation of 2dpf old zebrafish embryos injected with Co-MO (6 ng), TB-MO kif21a (2 ng) or SB-MO kif21a (6 ng). The barchart represents the pooled data from 3 or 4 independent experiments for each condition, respectively; number (n) of total embryos analysed: Co-MO, n = 390; TB-MO kif21a, n = 384 and Co-MO, n = 290; SB-MO kif21a, n = 290. (F) Bright-field images of zebrafish embryos at 2dpf injected with Co-MO (6 ng), TB-MO kif21a (2 ng) or SB-MO kif21a (6 ng) (black arrowhead points to pericardial edema formation). Unprocessed blot and gel images (A and B, respectively) are presented in Supplementary Fig. S3.
Figure 3
Figure 3
Kif21a deficiency results in defective podocyte morphology leading in a leaky glomerular filtration barrier and proteinuria. (A) Representative electron micrographs of glomerular region from 5dpf old zebrafish embryos injected with Co-MO (6 ng), TB-MO kif21a (1 ng) or SB-MO kif21a (6 ng). Green, blue and magenta arrowheads point to podocyte foot processes, podocyte foot process effacements and slit diaphragms, respectively. Black arrows point to glomerular basement membrane. Yellow-framed boxes represent magnifications of respective insets. Bowman’s space (BS), capillary lumen (CL), fenestrated endothelial cell (EC). Scale bars represent 500 nm. (B) Representative confocal images of 4dpf old Tg(cdh17:mcherry) embryos (expressing red fluorescent reporter protein in the pronephric tubules) injected with Co-MO (2 ng), TB-MO kif21a (1 ng) or SB-MO nephrin (2 ng) that were injected with 500 kDa FITC-dextran into the common cardinal vein at 80hpf. White arrowheads indicate the presence of 500 kDa FITC-dextran in the pronephric tubule lumen. (C) Quantification of 4dpf old embryos injected with Co-MO (2 ng), TB-MO kif21a (1 ng) or SB-MO nephrin (2 ng) that show the presence of 500 kDa FITC-dextran in their pronephric tubule lumen. The knockdown of nephrin, a well-established zebrafish model causing dysfunction of the GFB and proteinuria, served as positive control. The barchart represents the pooled data from 10 independent experiments for each condition; number (n) of total embryos analysed: Co-MO, n = 98; TB-MO kif21a, n = 100; SB-MO nephrin, n = 92). (D) SDS-PAGE analysis of processed urine samples of embryos injected with Co-MO (2 ng) or TB-MO kif21a (2 ng) for the identification of proteinuria. Bovine serum albumin (BSA) was used as positive control. (E) SDS-PAGE analysis of processed urine samples of embryos injected with Co-MO (6 ng) or SB-MO kif21a (6 ng) for the identification of proteinuria. BSA was used as positive control. (F) Quantification of SDS-PAGE signal intensity of embryos injected with Co-MO (2 or 6 ng), TB-MO kif21a (2 ng) or SB-MO kif21a (6 ng). The barchart represents the pooled data from 3 independent experiments for each condition. Unprocessed SDS-PAGE images (D and E) are presented in Supplementary Fig. S4.

Similar articles

Cited by

References

    1. Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733. doi: 10.1016/S0140-6736(20)30045-3. - DOI - PMC - PubMed
    1. Li AS, Ingham JF, Lennon R. Genetic disorders of the glomerular filtration barrier. Clin J Am Soc Nephrol. 2020;15:1818–1828. doi: 10.2215/CJN.11440919. - DOI - PMC - PubMed
    1. Benzing T, Salant D. Insights into glomerular filtration and albuminuria. N Engl J Med. 2021;384:1437–1446. doi: 10.1056/NEJMra1808786. - DOI - PubMed
    1. Daehn IS, Duffield JS. The glomerular filtration barrier: a structural target for novel kidney therapies. Nat Rev Drug Discov. 2021;20:770–788. doi: 10.1038/s41573-021-00242-0. - DOI - PMC - PubMed
    1. Kopp JB, et al. Podocytopathies. Nat Rev Dis Primers. 2020;6:68. doi: 10.1038/s41572-020-0196-7. - DOI - PMC - PubMed

Publication types

LinkOut - more resources